Welcome to LookChem.com Sign In|Join Free
  • or
3-Quinolinecarboxylicacid,7-amino-4-hydroxy-(9CI) is a chemical compound with the molecular formula C10H8N2O3. It is a derivative of quinolinecarboxylic acid, containing an amino group at the seventh position and a hydroxy group at the fourth position. This versatile compound is commonly used in pharmaceutical and medicinal research due to its potential biological activities, including antiviral, antibacterial, and antifungal properties. Additionally, it is being studied for its potential as an anti-inflammatory and antioxidant agent.

85344-88-3

Post Buying Request

85344-88-3 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

85344-88-3 Usage

Uses

Used in Pharmaceutical Industry:
3-Quinolinecarboxylicacid,7-amino-4-hydroxy-(9CI) is used as an active pharmaceutical ingredient for the development of drugs with antiviral, antibacterial, and antifungal properties. Its potential biological activities make it a promising candidate for the treatment of various infections and diseases caused by viruses, bacteria, and fungi.
Used in Medicinal Research:
3-Quinolinecarboxylicacid,7-amino-4-hydroxy-(9CI) is used as a research compound for studying its potential as an anti-inflammatory and antioxidant agent. Its ability to modulate inflammation and oxidative stress pathways could lead to the development of new therapeutic agents for the treatment of inflammatory and oxidative stress-related disorders.
Used in Drug Development:
3-Quinolinecarboxylicacid,7-amino-4-hydroxy-(9CI) is used as a key building block in the synthesis of various drug candidates. Its unique chemical structure and functional groups enable the development of novel compounds with improved pharmacological properties and therapeutic potential.
Used in Disease Treatment:
3-Quinolinecarboxylicacid,7-amino-4-hydroxy-(9CI) is used as a therapeutic agent for the treatment of various diseases and conditions. Its broad-spectrum antimicrobial activity, along with its potential anti-inflammatory and antioxidant properties, make it a valuable tool in the management and treatment of a wide range of diseases.

Check Digit Verification of cas no

The CAS Registry Mumber 85344-88-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,5,3,4 and 4 respectively; the second part has 2 digits, 8 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 85344-88:
(7*8)+(6*5)+(5*3)+(4*4)+(3*4)+(2*8)+(1*8)=153
153 % 10 = 3
So 85344-88-3 is a valid CAS Registry Number.

85344-88-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 20, 2017

Revision Date: Aug 20, 2017

1.Identification

1.1 GHS Product identifier

Product name 7-Amino-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid

1.2 Other means of identification

Product number -
Other names 7-amino-1H-[1,2,3]triazolo[4,5-d]pyrimidine-5-thiol

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:85344-88-3 SDS

85344-88-3Relevant academic research and scientific papers

The inhibition of factor inhibiting hypoxia-inducible factor (FIH) by β-oxocarboxylic acids

Banerji, Biswadip,Conejo-Garcia, Ana,McNeill, Luke A.,McDonough, Michael A.,Buck, Matthew R. G.,Hewitson, Kirsty S.,Oldham, Neil J.,Schofield, Christopher J.

, p. 5438 - 5440 (2008/01/27)

Cyclic β-oxocarboxylic acids inhibit factor inhibiting hypoxia-inducible factor via ligation to the active site iron. The Royal Society of Chemistry 2005.

Synthesis of 1,4-Dihydro-4-oxo-quinoline-3-carboxylic Acid Derivatives as Inhibitors of Rat Lens Aldose Reductase

Bueyuekbingoel, Erdem,Das, Net,Klopman, Gilles

, p. 129 - 132 (2007/10/02)

The title compounds were prepared according to Scheme 2 and tested as inhibitors of the aldose reductase of rat lens.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 85344-88-3